These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 28722622

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J, Santos MD, Roux A, LE Maignan C, Guillot J, Lavarde V, Cornet M.
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [Abstract] [Full Text] [Related]

  • 23. Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE.
    Mounsey K, Kearns T, Rampton M, Llewellyn S, King M, Holt D, Currie BJ, Andrews R, Nutman T, McCarthy J.
    Acta Trop; 2014 Oct; 138():78-82. PubMed ID: 25051188
    [Abstract] [Full Text] [Related]

  • 24. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
    Lichtenberger P, Rosa-Cunha I, Morris M, Nishida S, Akpinar E, Gaitan J, Tzakis A, Doblecki-Lewis S.
    Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
    [Abstract] [Full Text] [Related]

  • 25. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J.
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
    Nontasut P, Muennoo C, Sa-nguankiat S, Fongsri S, Vichit A.
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
    [Abstract] [Full Text] [Related]

  • 27. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.
    Donadello K, Cristallini S, Taccone FS, Lorent S, Vincent JL, de Backer D, Jacobs F.
    Int J Antimicrob Agents; 2013 Dec; 42(6):580-3. PubMed ID: 24269075
    [Abstract] [Full Text] [Related]

  • 28. Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
    Marks M, Gwyn S, Toloka H, Kositz C, Asugeni J, Asugeni R, Diau J, Kaldor JM, Romani L, Redman-MacLaren M, MacLaren D, Solomon AW, Mabey DCW, Steer AC, Martin D.
    Clin Infect Dis; 2020 Dec 15; 71(12):3226-3228. PubMed ID: 32421762
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of ivermectin to control Strongyloides stercoralis infection in sheltered dogs.
    Paradies P, Buonfrate D, Iatta R, Iarussi F, Giorli G, Palmieri VO, Sasanelli M, Perandin F, Šlapeta J, Capogna A, Otranto D, Bisoffi Z.
    Acta Trop; 2019 Feb 15; 190():204-209. PubMed ID: 30465740
    [Abstract] [Full Text] [Related]

  • 30. Effective diagnostic tests and anthelmintic treatment for Strongyloides stercoralis make community control feasible.
    Shield JM, Page W.
    P N G Med J; 2008 Feb 15; 51(3-4):105-19. PubMed ID: 21061942
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Strongyloides stercoralis infection in an intestinal transplant recipient.
    Hsu CN, Tseng SH, Chang SW, Chen Y.
    Transpl Infect Dis; 2013 Aug 15; 15(4):E139-43. PubMed ID: 23789974
    [Abstract] [Full Text] [Related]

  • 33. Field survey for strongyloidiasis in eastern Uganda with observations on efficacy of preventive chemotherapy and co-occurrence of soil-transmitted helminthiasis/intestinal schistosomiasis.
    Sousa-Figueiredo JC, Day M, Betson M, Rowell C, Wamboko A, Arinaitwe M, Kazibwe F, Kabatereine NB, Stothard JR.
    J Helminthol; 2011 Sep 15; 85(3):325-33. PubMed ID: 20961473
    [Abstract] [Full Text] [Related]

  • 34. [Strongyloides stercoralis infection simulating polyarteritis nodosa].
    Masseau A, Hervier B, Leclair F, Grossi O, Mosnier JF, Hamidou M.
    Rev Med Interne; 2005 Aug 15; 26(8):661-3. PubMed ID: 15949873
    [Abstract] [Full Text] [Related]

  • 35. High prevalence of Strongyloides stercoralis among school children in rural Côte d'Ivoire.
    Glinz D, N'Guessan NA, Utzinger J, N'Goran EK.
    J Parasitol; 2010 Apr 15; 96(2):431-3. PubMed ID: 19916629
    [Abstract] [Full Text] [Related]

  • 36. Ivermectin concentration in breastmilk of a woman with Strongyloides stercoralis and human T-lymphotropic virus-I co-infection.
    Rodari P, Buonfrate D, Pomari E, Lunardi G, Bon I, Bisoffi Z, Angheben A.
    Acta Trop; 2020 Feb 15; 202():105249. PubMed ID: 31678122
    [Abstract] [Full Text] [Related]

  • 37. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
    Rebollo MP, Bockarie MJ.
    Expert Rev Anti Infect Ther; 2013 Jul 15; 11(7):723-31. PubMed ID: 23879610
    [Abstract] [Full Text] [Related]

  • 38. Control programs for strongyloidiasis in areas of high endemicity: an economic analysis of different approaches.
    Buonfrate D, Zammarchi L, Bisoffi Z, Montresor A, Boccalini S.
    Infect Dis Poverty; 2021 May 25; 10(1):76. PubMed ID: 34030741
    [Abstract] [Full Text] [Related]

  • 39. Mass Drug Administration for the Control of Strongyloides stercoralis Infection: Progress and Challenges.
    Amato VS, Tuon FF.
    Clin Infect Dis; 2020 Dec 15; 71(12):3229-3231. PubMed ID: 32421778
    [No Abstract] [Full Text] [Related]

  • 40. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
    Muennig P, Pallin D, Challah C, Khan K.
    Epidemiol Infect; 2004 Dec 15; 132(6):1055-63. PubMed ID: 15635962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.